sulfasalazine has been researched along with Granulomatosis, Wegener's in 3 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alokaily, F | 1 |
| AlKathiri, R | 1 |
| AlKathiri, S | 1 |
| Alrashidi, S | 1 |
| Scherer, HU | 1 |
| Burmester, GR | 1 |
| Salerno, SM | 1 |
| Ormseth, EJ | 1 |
| Roth, BJ | 1 |
| Meyer, CA | 1 |
| Christensen, ED | 1 |
| Dillard, TA | 1 |
1 review available for sulfasalazine and Granulomatosis, Wegener's
| Article | Year |
|---|---|
[Biologicals in the treatment of rheumatic diseases].
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monocl | 2006 |
2 other studies available for sulfasalazine and Granulomatosis, Wegener's
| Article | Year |
|---|---|
A limited form of granulomatosis with polyangiitis in an ulcerative colitis patient receiving sulfasalazine.
Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Biopsy; Colitis, Ulcerative; Female; Granulomatosis w | 2022 |
Sulfasalazine pulmonary toxicity in ulcerative colitis mimicking clinical features of Wegener's granulomatosis.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Colitis, Ul | 1996 |